+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

Levodopa - Global Strategic Business Report - Product Thumbnail Image

Levodopa - Global Strategic Business Report

  • Report
  • June 2025
  • 377 Pages
  • Global
From
Restless Legs Syndrome - Global Strategic Business Report - Product Thumbnail Image

Restless Legs Syndrome - Global Strategic Business Report

  • Report
  • June 2025
  • 290 Pages
  • Global
From
From
From
From
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 93 Pages
  • Global
From
From
From
From
From
From
From
Peripheral Neuropathy Treatment Market 2025-2029 - Product Thumbnail Image

Peripheral Neuropathy Treatment Market 2025-2029

  • Report
  • April 2025
  • 233 Pages
  • Global
From
From
Loading Indicator